Effects and mechanisms of Supplemented Shenqi Dihuang Decoction Formula in improving podocyte pyroptosis in diabetic kidney disease by regulating dyslipidemia-mediated lipid droplet accumulation and TLR4/MyD88/NF-κB pathway

Farxiga (dapagliflozin) - AstraZeneca

resatorvid (TAK-242) - Takeda, Akaza Bioscience

http://www.ncbi.nlm.nih.gov/pubmed/41814794

Fee-Lan Chong; Hao-Wen Shen; Ping Chen; Qi-Han He; Qi-Jun Fang; Tian-Qing Sang; Wei Wu; Xin-Mei Xu; Ya-Jing Li; Yi-Gang Wan; Ying-Lu Liu

Mar 12, 2026